Xu, P., Hong, F., Wang, J., Wang, J., Zhao, X., Wang, S., . . . Zhai, Y. (2017). DBZ is a putative PPARγ agonist that prevents high fat diet-induced obesity, insulin resistance and gut dysbiosis. Biochimica et biophysica acta. General subjects, 1861(11), 2690-2701. https://doi.org/10.1016/j.bbagen.2017.07.013
Chicago Style (17th ed.) CitationXu, Pengfei, et al. "DBZ Is a Putative PPARγ Agonist That Prevents High Fat Diet-induced Obesity, Insulin Resistance and Gut Dysbiosis." Biochimica Et Biophysica Acta. General Subjects 1861, no. 11 (2017): 2690-2701. https://doi.org/10.1016/j.bbagen.2017.07.013.
MLA (9th ed.) CitationXu, Pengfei, et al. "DBZ Is a Putative PPARγ Agonist That Prevents High Fat Diet-induced Obesity, Insulin Resistance and Gut Dysbiosis." Biochimica Et Biophysica Acta. General Subjects, vol. 1861, no. 11, 2017, pp. 2690-2701, https://doi.org/10.1016/j.bbagen.2017.07.013.